These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34656039)

  • 1. Comparing mortality from covid-19 to mortality due to overdose: A micromort analysis.
    Lee Y; Lui LMW; Brietzke E; Liao Y; Lu C; Ho R; Subramaniapillai M; Mansur RB; Rosenblat JD; McIntyre RS
    J Affect Disord; 2022 Jan; 296():514-521. PubMed ID: 34656039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overdose deaths and the COVID-19 pandemic in British Columbia, Canada.
    Palis H; Bélair MA; Hu K; Tu A; Buxton J; Slaunwhite A
    Drug Alcohol Rev; 2022 May; 41(4):912-917. PubMed ID: 34908203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
    Foreman-Mackey A; Xavier J; Corser J; Fleury M; Lock K; Mehta A; Lamb J; McDougall J; Newman C; Buxton JA
    BMC Public Health; 2023 Apr; 23(1):640. PubMed ID: 37013524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia: a mixed-method study protocol.
    Nosyk B; Slaunwhite A; Urbanoski K; Hongdilokkul N; Palis H; Lock K; Min JE; Zhao B; Card KG; Barker B; Meilleur L; Burmeister C; Thomson E; Beck-McGreevy P; Pauly B
    BMJ Open; 2021 Jun; 11(6):e048353. PubMed ID: 34108170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and overdose prevention: Challenges and opportunities for clinical practice in housing settings.
    MacKinnon L; Socías ME; Bardwell G
    J Subst Abuse Treat; 2020 Dec; 119():108153. PubMed ID: 33032862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fentanyl and heroin contained in seized illicit drugs and overdose-related deaths in British Columbia, Canada: An observational analysis.
    Baldwin N; Gray R; Goel A; Wood E; Buxton JA; Rieb LM
    Drug Alcohol Depend; 2018 Apr; 185():322-327. PubMed ID: 29486421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Socioeconomic factors and substances involved in poisoning-related emergency department visits in British Columbia, Canada.
    Pawer S; Rajabali F; Zheng A; Pike I; Purssell R; Zargaran A; Babul S
    Health Promot Chronic Dis Prev Can; 2021; 41(7-8):211-221. PubMed ID: 34427419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.
    Irvine MA; Kuo M; Buxton JA; Balshaw R; Otterstatter M; Macdougall L; Milloy MJ; Bharmal A; Henry B; Tyndall M; Coombs D; Gilbert M
    Addiction; 2019 Sep; 114(9):1602-1613. PubMed ID: 31166621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of overdose and non-overdose mortality among people living with HIV amidst the illicit drug toxicity crisis in British Columbia.
    Yazdani K; Dhillon N; Tung A; Ye M; Trigg J; Stanley C; Ni Gusti Ayu N; McLinden T; Lima VD; Barrios R; Hogg R; Montaner JSG; Salters K
    AIDS Care; 2024 Feb; 36(2):263-271. PubMed ID: 37094365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characteristics of the Provincial Overdose Cohort in British Columbia, Canada.
    MacDougall L; Smolina K; Otterstatter M; Zhao B; Chong M; Godfrey D; Mussavi-Rizi A; Sutherland J; Kuo M; Kendall P
    PLoS One; 2019; 14(1):e0210129. PubMed ID: 30629607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
    Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
    Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overdose and risk factors for coronavirus disease 2019.
    Slaunwhite AK; Gan WQ; Xavier C; Zhao B; Buxton JA; Desai R
    Drug Alcohol Depend; 2020 Jul; 212():108047. PubMed ID: 32447172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: a systematic review of observational studies and analysis of public health surveillance data.
    Imtiaz S; Nafeh F; Russell C; Ali F; Elton-Marshall T; Rehm J
    Subst Abuse Treat Prev Policy; 2021 Nov; 16(1):87. PubMed ID: 34844624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative changes in illicit drug supply during COVID-19: Associations with use of overdose prevention and health services among women sex workers who use drugs (2020-2021).
    Moreheart S; Shannon K; Krüsi A; McDermid J; Ettinger E; Braschel M; Goldenberg SM
    Int J Drug Policy; 2023 Nov; 121():104212. PubMed ID: 37797570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect.
    Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA
    Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Illicit drug overdose deaths resulting from income assistance payments: Analysis of the 'check effect' using daily mortality data.
    Otterstatter MC; Amlani A; Guan TH; Richardson L; Buxton JA
    Int J Drug Policy; 2016 Jul; 33():83-7. PubMed ID: 27402469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicaid expansion and drug overdose mortality during the COVID-19 pandemic in the United States.
    Auty SG; Griffith KN
    Drug Alcohol Depend; 2022 Mar; 232():109340. PubMed ID: 35131533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. People who use drugs' prioritization of regulation amid decriminalization reforms in British Columbia, Canada: A qualitative study.
    Xavier JC; McDermid J; Buxton J; Henderson I; Streukens A; Lamb J; Greer A
    Int J Drug Policy; 2024 Mar; 125():104354. PubMed ID: 38402802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ecological study of the correlation between COVID-19 support payments and overdose events in British Columbia, Canada.
    Richardson L; Geddes C; Palis H; Buxton J; Slaunwhite A
    Int J Drug Policy; 2024 Apr; 126():104362. PubMed ID: 38484530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the socioeconomic profile of people who experienced opioid overdoses in British Columbia, 2014 to 2016.
    Carrière G; Garner R; Sanmartin C
    Health Rep; 2021 Feb; 32(2):27-38. PubMed ID: 33595226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.